Literatur
Siegel I (1963) Conception control by long-acting progestogens: Preliminary report. Obstet Gynecol 21:666–668
WHO (1988) Task Force on Long-acting Systemic Agents for Fertility Regulation, Special Programm of Research, Development and Research Training in Human Reproduction. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: Contraceptive efficacy and side effects. Contraception 37:1–20
WHO (1991) collaborative study of neoplasia and steroid contraceptives. Breast cancer and depot-medroxyprogesterone acetate: a multinational study. Lancet 338:833–838
WHO (1986) Depot-Medroxprogesterone acetate (DMPA) and cancer: Memorandum from a WHO Meeting. Bulletin of the World Health Organisation, 64:375–382
WHO (1982) Facts about injectable contraceptives. Bulletin of the World Health Organisation, 60:199–210
Liskin LS, Quillin WF (1983) Population Reports. Long-Acting Progestins-Promise and Prospects. XI, [2] K 17-K 55
Sang G (1994) Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception, 49:361–385
Fraser IS (1994) Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception, 49:399–420
Koetsawang S (1994) Once-a-month injectable contraceptives: Efficacy and reasons for discontinuation. Contraception, 49:387–398
Rights and permissions
About this article
Cite this article
Zahradnik, H.P. Depotgestagene. Arch Gynecol Obstet 257, 536–541 (1995). https://doi.org/10.1007/BF02264884
Issue Date:
DOI: https://doi.org/10.1007/BF02264884